Abstract
Background Antimicrobials are only indicated in acute childhood diarrhea when the infection is invasive (and therefore often bloody), or persistent. Rapid and cost-effective screening for invasive diarrhea at the point of care can therefore inform treatment decisions. Multiple rapid fecal occult blood testing (FOBT) kit brands are widely available in Nigeria. This study aimed to compare the diagnostic utility of locally procurable FOBT kits in invasive infantile diarrhea to the innovators product, using fecal microscopy as the gold standard.
Materials and Methods Fecal specimens from 46 children under 5 years old with diarrhea, being collected as part of ongoing case-control studies, were tested according to manufacturers’ instructions for each of five FOBT kits. Fecal microscopy for occult blood, and culture for bacterial pathogens were also performed concomitantly using standard procedures.
Results Stool microscopy confirmed almost ubiquitous presence of white blood cells in stool from children with diarrhea, whereas red blood cells were less commonly detected. A positive FOBT reaction was only seen when red blood cells were present at more than trace levels and was partially correlated with the presence of a potentially invasive pathogen. Each of the five FOBT kits tested showed 54-61% sensitivity, 87-90% specificity, and acceptable positive- and negative-predictive values for invasive diarrhea.
Conclusions Four inexpensive, locally available kits identified invasive pediatric diarrheas showed reasonable performance for detecting likely invasive diarrhea and performed similarly to the more difficult-to-procure innovator’s product. FOBT kits are a rapid option for presumptive diagnosis of invasive diarrhea, are a viable alternative to stool microscopy for paediatric specimens at the point-of-care, and could serve as early warning indicators for dysentery outbreaks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by an African Research Leader’s Award to INO. The award is funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union. INO is a Calestous Juma Science Leadership Fellow supported by the Bill and Melinda Gates Foundation. The funders played no role in the design, execution or decision to publish this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for this work was obtained from the UI/UCH ethics committee (approval number UI/EC/15/093). Study participants’ guardians provided written informed consent for their participation in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Sequence data were submitted to ENA and are available from ENA https://www.ebi.ac.uk/ena/browser/home and Genbank https://www.ncbi.nlm.nih.gov/genbank/ as Bioproject PRJEB8667. All other data are contained in the manuscript.
